Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|April 13, 2000
IL-12- and IL-2-induced tumor regression in a new murine model of oral squamous-cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-gammaG R Thomas, Z Chen, I Enamorado, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2001
NIH symposium summary: organ preservation therapies for squamous cancers of the head and neckB A Conley, R Cumberlin, A Sandberg, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1997
Genes differentially expressed with malignant transformation and metastatic tumor progression of murine squamous cell carcinomaG Dong, E Loukinova, C W Smith, et al.
The Journal of Experimental Medicine|November 1, 1986
Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transferH J Stauss, C Van Waes, M A Fink, et al.
Oral Diseases|November 14, 2013
The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapiesR Vander Broek, S Mohan, D F Eytan, et al.
The Journal of Experimental Medicine|November 1, 1986
Highly malignant tumor variants retain tumor-specific antigens recognized by T helper cellsC Van Waes, J L Urban, J L Rothstein, et al.
The Journal of Experimental Medicine|November 1, 1985
Multiple cancers. Tumor burden permits the outgrowth of other cancersC A Mullen, J L Urban, C Van Waes, et al.
Journal of Environmental Management|April 14, 2017
Potential of chopped heath biomass and spent growth media to replace wood chips as bulking agent for composting high N-containing residuesJ Viaene, B Reubens, K Willekens, et al.
International Journal of Cancer|July 10, 1999
Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinomaG R Thomas, Z Chen, M N Oechsli, et al.
Tissue Antigens|May 1, 1996
Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitroC Van Waes, P A Monach, J L Urban, et al.
Pageof 5